Marc L Gordon MD
Dementia & Geriatrics
Chief of Neurology at the Zucker Hillside Hospital, and Associate Professor of Neurology and Psychiatry at the Hofstra Northwell School of Medicine
Join to View Full Profile
611 Northern BlvdSte 150Great Neck, NY 11021
Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Marc Gordon, MD, is a neurologist based in Great Neck, NY, specializing in dementia and geriatrics. He completed his residency in neurology at Montefiore Medical Center from 1986 to 1990, following an internship in internal medicine at Zucker School of Medicine at Hofstra/Northwell at Lenox Hill Hospital. Dr. Gordon's educational background includes a medical degree from Columbia University Vagelos College of Physicians and Surgeons. His professional experience encompasses general neurology, sleep medicine, addiction medicine, Alzheimer's disease, and behavioral neurology/neuropsychiatry. He has contributed to several publications related to Alzheimer's and neurodegenerative disorders and has been involved in clinical trials such as the Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease. He has been recognized with honors including being listed as one of the Top Doctors in the New York Metro Area by Castle Connolly and receiving the CMS Meaningful Use Stage 1 Certification.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1986 - 1990
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalInternship, Internal Medicine, 1985 - 1986
Columbia University Vagelos College of Physicians and SurgeonsClass of 1985
Certifications & Licensure
NY State Medical License 1986 - 2028
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2014, 2016-2017
Clinical Trials
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- Utility of [F]PI-2620 as Universal Biomarker for the Amyloid/Tau/Neurodegeneration Classification of Alzheimer Disease: An Exploratory Study with Dual-Phase PET Imaging.Ana M Franceschi, Shichun Peng, Jorge Irias Banegas, Graham Keir, Marc L Gordon
AJNR. American Journal of Neuroradiology. 2026-02-03 - 5 citationsNovel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, ...Hyun Kim, Seonjoo Lee, Alina Levine, Benjamin Huber, Howard Andrews
Alzheimer's & Dementia. 2024-08-01 - 1 citationsMemories and mimics: unveiling the potential of FDG-PET in guiding therapeutic approaches for neurodegenerative cognitive disorders.Brendan Huang, Sara Sawicki, Carolyn Habiger, Paul J Mattis, Marc L Gordon
Frontiers in Neurology. 2024-01-01
Press Mentions
Harvard Study Links Loss of Metal Lithium to Alzheimer's Disease, Giving Hope on Long IslandAugust 9th, 2025- Depression Sometimes Early Sign of Alzheimer’s DiseaseAugust 30th, 2024
- New Dementia Treatment? How an HIV Drug May Help Prevent Protein Build-up in the BrainApril 26th, 2023
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
